InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+58.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Demski David M, Director. Insider active across 3 companies, notably Axonics, Inc.. In total, 15 disclosures have been recorded. Split: 3 buys · 1 sell. Total volume traded: €1.3m. Activity tracked since 22 October 2021. The latest transaction was filed on 11 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
32,012 sharesCommon StockSEC:0001555392-26-000002:0
30,000 shares@ US$21.2040.7% of flowCommon StockSEC:0001555392-25-000004:0
15,131 shares0Common StockSEC:0001415889-25-017263:0
74,307 sharesCommon StockSEC:0000950170-25-056357:0
126,051 sharesCommon StockSEC:0001415889-24-029768:0
34,207 shares0Common StockSEC:0001610717-24-000536:0
9,542 shares@ US$71.00100.0% of flowCommon StockSEC:0001562180-24-007703:0
50,000 shares@ US$5.6732.1% of flowCommon StockSEC:0001415889-24-021972:0
Ideal exit: 18 May 2025 (T+270)
40,000 shares@ US$6.5630.7% of flowCommon StockSEC:0001415889-24-020724:0
Ideal exit: 29 Apr 2025 (T+270)
16,747 shares0Common StockSEC:0001415889-24-016931:0
30,000 shares@ US$10.5037.2% of flowCommon StockSEC:0001415889-23-014991:0
Ideal exit: 5 Aug 2024 (T+270)
7,842 shares0Common StockSEC:0001415889-23-014428:0
3,000 shares0Common StockSEC:0001562180-23-005534:0
2,100 shares0Common StockSEC:0001562180-22-006266:0
942 shares0Common StockSEC:0001562180-21-006777:0
15 of 15 declarations
About Demski David M
David M. Demski is a Board Member of Axonics, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the medical technology sector allows him to provide valuable insights to board discussions, contributing to the company's growth and innovation.
